Molecular Imaging Program

Grant Funding

SARC Sarcoma SPORE: “Project 4: Development of quantitative imaging biomarkers for assessing response to sarcoma therapy.” HCI PI: Jeffrey Yap, SPORE PI: Raphael Pollock, The Ohio State University.

This project seeks to develop new imaging approaches using MRI and PET to non-invasively measure various aspects of tumor biology and pathophysiology in response to conventional and experimental chemotherapies.  This will enable a powerful set of tools to evaluate treatment efficacy and ultimately improve the development of new drugs and clinical management of sarcoma patients.  This is a subcontract to SARC.